|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 53 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Director |
|
2012-03-01 |
4 |
B |
$29.47 |
$11,936 |
I/I |
405 |
220,223 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-02 |
4 |
B |
$29.52 |
$323,899 |
I/I |
10,972 |
1,461,872 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-02 |
4 |
B |
$29.52 |
$2,699,915 |
I/I |
91,459 |
8,058,823 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-02 |
4 |
B |
$29.52 |
$71,410 |
I/I |
2,419 |
222,642 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-05 |
4 |
B |
$29.96 |
$558,037 |
I/I |
18,597 |
1,480,469 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-05 |
4 |
B |
$29.96 |
$4,651,479 |
I/I |
155,014 |
8,213,837 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-05 |
4 |
B |
$29.96 |
$122,998 |
I/I |
4,099 |
226,741 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-07 |
4 |
B |
$29.88 |
$17,420 |
I/I |
583 |
227,324 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-07 |
4 |
B |
$29.88 |
$659,464 |
I/I |
22,071 |
8,235,908 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-07 |
4 |
B |
$29.88 |
$70,097 |
I/I |
2,346 |
1,482,815 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-08 |
4 |
B |
$30.36 |
$15,668 |
I/I |
516 |
227,840 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-08 |
4 |
B |
$30.36 |
$592,489 |
I/I |
19,513 |
8,255,421 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-03-08 |
4 |
B |
$30.36 |
$65,647 |
I/I |
2,162 |
1,484,977 |
2.25 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2012-03-12 |
4 |
B |
$1.87 |
$229,685 |
I/I |
94,306 |
204,336 |
1.5 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2012-03-12 |
4 |
B |
$1.87 |
$61,629 |
I/I |
25,304 |
51,126 |
1.5 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2012-03-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
110,030 |
|
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2012-03-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
25,822 |
|
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2012-03-13 |
4 |
B |
$2.96 |
$46,143 |
I/I |
15,599 |
219,935 |
1.5 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2012-03-13 |
4 |
B |
$2.96 |
$12,383 |
I/I |
4,186 |
55,312 |
1.5 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2012-03-14 |
4 |
B |
$2.99 |
$36,172 |
I/I |
12,076 |
232,011 |
1.5 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2012-03-14 |
4 |
B |
$2.99 |
$7,165 |
I/I |
2,392 |
57,704 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-04 |
4 |
B |
$27.99 |
$1,488,643 |
I/I |
53,128 |
229,149 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-07 |
4 |
B |
$28.25 |
$1,597,965 |
I/I |
56,540 |
230,439 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-08 |
4 |
B |
$28.41 |
$2,480,619 |
I/I |
86,033 |
232,464 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-09 |
4 |
B |
$29.90 |
$584,367 |
I/I |
19,547 |
232,924 |
2.25 |
- |
|
1397 Records found
|
|
Page 53 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|